The Vanguard Group 13D/13G Filings for Altimmune, Inc. (ALT)

The Vanguard Group 13D and 13G filings for Altimmune, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-13
4:58 pm
Purchase
2023-12-29 13G Altimmune, Inc.
ALT
The Vanguard Group 3,571,972
6.650%
1,039,552increase
(+41.05%)
Filing
2023-02-09
11:07 am
Purchase
2022-12-30 13G Altimmune, Inc.
ALT
The Vanguard Group 2,532,420
5.150%
2,532,420increase
(New Position)
Filing